These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16289658)

  • 1. Leukemia virus long terminal repeat activates NFkappaB pathway by a TLR3-dependent mechanism.
    Abujamra AL; Spanjaard RA; Akinsheye I; Zhao X; Faller DV; Ghosh SK
    Virology; 2006 Feb; 345(2):390-403. PubMed ID: 16289658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations that abrogate transactivational activity of the feline leukemia virus long terminal repeat do not affect virus replication.
    Abujamra AL; Faller DV; Ghosh SK
    Virology; 2003 May; 309(2):294-305. PubMed ID: 12758176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feline leukemia virus long terminal repeat activates collagenase IV gene expression through AP-1.
    Ghosh SK; Faller DV
    J Virol; 1999 Jun; 73(6):4931-40. PubMed ID: 10233955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites.
    Johnson C; Lobelle-Rich PA; Puetter A; Levy LS
    J Virol; 2005 Jan; 79(1):57-66. PubMed ID: 15596801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long terminal repeat regions from exogenous but not endogenous feline leukemia viruses transactivate cellular gene expression.
    Ghosh SK; Roy-Burman P; Faller DV
    J Virol; 2000 Oct; 74(20):9742-8. PubMed ID: 11000248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA polymerase III control elements are required for trans-activation by the murine retroviral long terminal repeat sequences.
    Hwang YW; Yoo NK; Yang HM; Choi SY
    Biochem Biophys Res Commun; 2015 Jan; 456(1):110-5. PubMed ID: 25446107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the disease potential of a recombinant retrovirus containing Friend murine leukemia virus sequences and a unique long terminal repeat from feline leukemia virus.
    Nishigaki K; Hanson C; Thompson D; Yugawa T; Hisasue M; Tsujimoto H; Ruscetti S
    J Virol; 2002 Feb; 76(3):1527-32. PubMed ID: 11773427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A transcript from the long terminal repeats of a murine retrovirus associated with trans activation of cellular genes.
    Choi SY; Faller DV
    J Virol; 1995 Nov; 69(11):7054-60. PubMed ID: 7474125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moloney murine leukemia virus long terminal repeat activates monocyte chemotactic protein-1 protein expression and chemotactic activity.
    Faller DV; Weng H; Graves DT; Choi SY
    J Cell Physiol; 1997 Aug; 172(2):240-52. PubMed ID: 9258345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of LTR-specific small non-coding RNA in FeLV infected cells.
    Forman LW; Pal-Ghosh R; Spanjaard RA; Faller DV; Ghosh SK
    FEBS Lett; 2009 Apr; 583(8):1386-90. PubMed ID: 19336234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of collagenase IV gene expression and enzymatic activity by the Moloney murine leukemia virus long terminal repeat.
    Faller DV; Weng H; Choi SY
    Virology; 1997 Jan; 227(2):331-42. PubMed ID: 9018132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long terminal repeats of a murine retrovirus encode a trans-activator for cellular genes.
    Choi SY; Faller DV
    J Biol Chem; 1994 Aug; 269(31):19691-4. PubMed ID: 8051046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumorigenic potential of a recombinant retrovirus containing sequences from Moloney murine leukemia virus and feline leukemia virus.
    Starkey CR; Lobelle-Rich PA; Granger SW; Brightman BK; Fan H; Levy LS
    J Virol; 1998 Feb; 72(2):1078-84. PubMed ID: 9445002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of FeLV-945 by c-Myb binding and CBP recruitment to the LTR.
    Finstad SL; Prabhu S; Rulli KR; Levy LS
    Virol J; 2004 Sep; 1():3. PubMed ID: 15507152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique long terminal repeat and surface glycoprotein gene sequences of feline leukemia virus as determinants of disease outcome.
    Chandhasin C; Coan PN; Pandrea I; Grant CK; Lobelle-Rich PA; Puetter A; Levy LS
    J Virol; 2005 May; 79(9):5278-87. PubMed ID: 15827142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicity.
    Pantginis J; Beaty RM; Levy LS; Lenz J
    J Virol; 1997 Dec; 71(12):9786-91. PubMed ID: 9371646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The FeLV-945 LTR confers a replicative advantage dependent on the presence of a tandem triplication.
    Prabhu S; Lobelle-Rich PA; Levy LS
    Virology; 1999 Oct; 263(2):460-70. PubMed ID: 10544118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Moloney leukemia retroviral long terminal repeat trans-activates AP-1-inducible genes and AP-1 transcription factor binding.
    Weng H; Choi SY; Faller DV
    J Biol Chem; 1995 Jun; 270(23):13637-44. PubMed ID: 7775415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Moloney murine leukemia virus-based retrovirus with 4070A long terminal repeat sequences induces a high incidence of myeloid as well as lymphoid neoplasms.
    Wolff L; Koller R; Hu X; Anver MR
    J Virol; 2003 Apr; 77(8):4965-71. PubMed ID: 12663802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous feline leukemia virus long terminal repeat integration site diversity is highly variable in related and unrelated domestic cats.
    Chiu ES; McDonald CA; Gagne RB; Dunkleberger H; Moxcey M; VandeWoude S
    Retrovirology; 2024 Feb; 21(1):3. PubMed ID: 38347535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.